About Upstream Medical Technologies
Upstream Medical Technologies is a company based in Dunedin (New Zealand) founded in 2015.. Upstream Medical Technologies has raised $5.52 million across 2 funding rounds from investors including European Investment Bank, IDEBET and Pacific Channel. Upstream Medical Technologies offers products and services including Marker C. Upstream Medical Technologies operates in a competitive market with competitors including SphingoTec, BG Medicine, Pronota, Critical Diagnostics and Shape Medical Systems, among others.
- Headquarter Dunedin, New Zealand
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Upstream Medical Technologies Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.52 M (USD)
in 2 rounds
-
Latest Funding Round
$5 M (USD), Series A
Jan 14, 2018
-
Investors
European Investment Bank
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Upstream Medical Technologies
Upstream Medical Technologies offers a comprehensive portfolio of products and services, including Marker C. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood test for rapid detection of unstable angina in at-risk patients.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Upstream Medical Technologies
Upstream Medical Technologies has successfully raised a total of $5.52M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $5.0M
-
First Round
First Round
(13 Nov 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Series A - Upstream Medical Technologies | Valuation | Innovator Capital , European Investment Bank |
|
| Nov, 2017 | Amount | Seed - Upstream Medical Technologies | Valuation | Pacific Channel |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Upstream Medical Technologies
Upstream Medical Technologies has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Investment Bank, IDEBET and Pacific Channel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Pacific Channel is engaged in deep-tech venture capital investment.
|
Founded Year | Domain | Location | |
|
IDEBET is recognized as a trending online slot gaming platform.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Upstream Medical Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Upstream Medical Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Upstream Medical Technologies Comparisons
Competitors of Upstream Medical Technologies
Upstream Medical Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SphingoTec, BG Medicine, Pronota, Critical Diagnostics and Shape Medical Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic tests for cardiovascular disorders are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Diagnostics for heart failure, pre-eclampsia, and sepsis are provided.
|
|
| domain | founded_year | HQ Location |
Biomarkers-based tests for cardiovascular disease diagnostics are developed.
|
|
| domain | founded_year | HQ Location |
Cardiopulmonary exercise testing technology is developed for heart failure detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Upstream Medical Technologies
Frequently Asked Questions about Upstream Medical Technologies
When was Upstream Medical Technologies founded?
Upstream Medical Technologies was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Upstream Medical Technologies located?
Upstream Medical Technologies is headquartered in Dunedin, New Zealand. It is registered at Dunedin, Otago, New Zealand.
Is Upstream Medical Technologies a funded company?
Upstream Medical Technologies is a funded company, having raised a total of $5.52M across 2 funding rounds to date. The company's 1st funding round was a Seed of $519.63K, raised on Nov 13, 2017.
What does Upstream Medical Technologies do?
Upstream Medical Technologies was established in 2015 as a spin-out from the University of Otago in Dunedin, New Zealand. Focus is placed on biomarker-based diagnostics within the medical technology sector. Seven patented cardiac biomarkers are employed to create devices for rapid heart disease detection. The lead product, BNP-sp, supports diagnosis of unstable angina, while Ghr-sp-Pne addresses heart failure alongside pneumonia. Operations center on advancing these testing solutions.
Who are the top competitors of Upstream Medical Technologies?
Upstream Medical Technologies's top competitors include SphingoTec, BG Medicine and Critical Diagnostics.
What products or services does Upstream Medical Technologies offer?
Upstream Medical Technologies offers Marker C.
Who are Upstream Medical Technologies's investors?
Upstream Medical Technologies has 3 investors. Key investors include European Investment Bank, IDEBET, and Pacific Channel.